IQOS に切り替えた、喫煙を継続した、または禁煙した成人喫煙患者における腹部大動脈瘤の増大の比較。

基本情報

NCT ID

NCT03837704

ステータス

完了

試験のフェーズ

該当なし

試験タイプ

介入

目標被験者数

48

治験依頼者名

Philip Morris Products S.A.

概要

The purpose of this study was to evaluate the reduction of the Abdominal Aortic Aneurysm (AAA) annual growth rate in patients who switched from smoking cigarettes to using IQOS as compared to patients who continued to smoke cigarettes, and to patients who had quit smoking. The study also aimed to provide context to the scale of reduction in the growth rate, by comparing the AAA annual growth rates for continuing to smoke and switching to IQOS with the AAA annual growth rate in smokers who had stopped smoking. The study further evaluated the effects of switching to IQOS on co-morbidities observed in AAA patients that are related to smoking as well as to assess the effects on relevant Biomarkers of Potential Harm (BoPH) linked to smoking related diseases.

対象疾患

介入

依頼者（Sponsor）

実施施設 (13)